Blog - Page 956 of 5701 - QualityStocks

TuesdayJun 14, 2022 3:34 pm

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Reaches Agreement with Philip Morris International Inc. (NYSE: PM) for International Electronic Nicotine Delivery System Product Distribution

Kaival Brands (NASDAQ: KAVL), the U.S. distributor of all products manufactured by Bidi Vapor LLC, which are intended for legal-age nicotine users, has inked an international licensing agreement with Philip Morris Products S.A. (“PMPSA”) for the development and distribution of electronic nicotine delivery system ("ENDS") products. Philip Morris Products is a wholly owned affiliate of Philip Morris International Inc. (NYSE: PM), and the agreement, which was finalized on June 13, 2022, covers products for markets outside of the United States. According to the announcement, the agreement between Kaival and PMPSA grants the latter the rights to manufacture, promote, sell and…

TuesdayJun 14, 2022 3:10 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Potential of UST(TM) as ‘Essential Tool in Future Beverage Development’

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and process development services to the worldwide food and beverage, biotherapeutics and other industries, today announced a pivotal peer-reviewed scientific publication. The piece highlights the use of PBI’s patented Ultra Shear Technology(TM) (“UST(TM)”) platform in the production of protein-enriched milk containing a novel emulsified plant-protein suspension. J.J. Janahar, et al., from The Ohio State University College of Food, Agricultural and Environmental Sciences (“CFAES”), in a study published in the high impact journal Food Hydrocolloids, reported that UST successfully created stable suspensions of…

TuesdayJun 14, 2022 2:48 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Results of Peer-Reviewed Study Published in International Journal

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has had its peer-reviewed scientific study published in the “International Journal of Molecular Sciences.” Titled “Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes,” the article reports on the study’s efforts to examine the biological activity of tetrahydrocannabivarin (“THCV”), cannabichromene (“CBC”) and other rare cannabinoids as well as the potential these substances have in addressing various skin conditions. The study used a recognized in vitro model of human keratinocytes to analyze how specific cannabinoids interacted with cannabinoid receptors and other endocannabinoid system…

TuesdayJun 14, 2022 2:26 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Announces Key Metrics, Plans to Take Creativity, Initiatives for Continued Growth to a New Level

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced results and initial trends of brand messaging, awareness and social media campaigns running over the previous nine months as it prepares new initiatives based on its continued growth and market opportunity. The results reflect the strong foundational elements of credibility that come with time, positive reviews and, most of all, success stories being told by artists, which the company continues to receive. “Our team’s focus and determination to turn out the best possible products, services and independent music artist solutions in general, is truly inspiring, taking creativity and initiatives…

TuesdayJun 14, 2022 1:43 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Featured in Recent Interview Released from Power Play by the Market Herald

Eat Well Group (CSE: EWG) (OTC: EWGFF), a publicly traded investment company, and CEO Marc Aneed are in the spotlight during the latest series of interviews released by the Power Play by the Market Herald. According to the announcement, Aneed spoke with Power Play host Sabrina Cuthbert about the company’s recent financial report. During the interview, Aneed discussed the news that Eat Well Group's portfolio companies generated combined revenues of $57,936,019 in fiscal year 2021. Total Eat Well Group assets at the company's fiscal year-end, including its portfolio companies, grew 1,082% to $59,627,414 as of Nov. 30, 2021. The spotlight…

TuesdayJun 14, 2022 12:00 pm

Speculation of Bear Market Reinforced by Crypto Declines and Cutbacks

Bitcoin reached an all-time low of $22,725 since December 2020 Other cryptos are feeling the strain, many of which are facing value declines of more than 30% in just a week Many crypto-focused companies have begun issuing hiring freezes and layoffs as a result of the low-valued prices Crypto exchange Gemini is laying off at least 10% of its employees, citing a turbulent market and “crypto winter” Speculation of a bear market has become a reality. Bitcoin just reached an all-time low (since December 2020), with a value of $23,981. Other cryptocurrencies are feeling the effects of this bear market…

TuesdayJun 14, 2022 11:15 am

Odyssey Health, Inc. (ODYY) Moving to Fill Gaps in Treatment and Management of Concussion Among Military Service Members

Odyssey is a medical company developing PRV-002, a novel compound for the treatment of concussion Between 75-83% of all the cases of traumatic brain injury (“TBI”) among U.S. service members have been classified as mild (“mTBI”), commonly termed “concussion” Although concussion greatly impacts the military, there are significant gaps in the understanding of the optimal diagnostic, treatment, and management criteria Odyssey is looking to bridge this informational gap with its clinical trial and intends to start its U.S. Phase II trials at military training sites, subject to the FDA’s approval of the results of its Phase I study The Center…

TuesdayJun 14, 2022 10:30 am

SPYR Inc. (SPYR) Grows its Footprint and Product Offering with GeoTraq, Inc. Acquisition

SPYR just completed the acquisition of GeoTraq as part of its 2022 expansion plan GeoTraq is known for its mission to simplify businesses with mobile IoT by providing low-cost IoT with plug-and-play functionality GeoTraq becomes the second company acquired by SPYR, following Applied Magix’s acquisition in 2020 SPYR (OTCQB: SPYR) recently completed the acquisition of GeoTraq, a Nevada-based enterprise that develops and manufactures advanced Internet of Things (“IoT”) modules for location-based services, asset tracking, and sensor modules for remote monitoring. The acquisition is in line with SPYR 2022 expansion plans to strengthen the company’s balance sheet while also growing shareholder…

TuesdayJun 14, 2022 9:45 am

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Increases Node Count on Bitcoin Lightning Network as Network Shows 300%+ Growth

The Lightning Network has seen growth of more than 300% since mid-2021, despite the recent decline of Bitcoin LQwD’s nodes on the Lightning Network include global coverage in Canada, South Korea, Brazil, Hong Kong, South Africa, Bahrain, Japan, the US, Ireland, India, Germany, Singapore, Sweden, Indonesia, Italy, France, and England The global cryptocurrency market was valued at US $1.49 billion in 2020, and is projected to reach US $4.94 billion by 2030 The Bitcoin Lightning Network (“LN”) has experienced explosive growth recently, despite the volatility of the cryptocurrency. Recent reports have indicated that Bitcoin has experienced negative growth – by…

TuesdayJun 14, 2022 9:00 am

Aditxt Inc.’s (NASDAQ: ADTX) AditxtScore(TM) Platform Provides Consumers and Physicians with Data Needed to Make Informed Health Decisions on COVID-19

Aditxt is a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system. The company’s AditxtScore(TM) for COVID-19 generates an AditxtScore(TM), which offers a detailed profile of a person’s immune response for SARS-CoV-2, allowing consumers and their physicians to understand, manage, and monitor their level of immune response to the virus, thus allowing them to make informed health decisions Aditxt’s platform is initially focusing on SARS-CoV-2, the virus that causes COVID-19, in recognition of the importance of immune monitoring and profiling in determining the course of action related to the virus. Though the COVID-19 pandemic…

Site Search

Company Search